vs
Ameris Bancorp（ABCB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Ameris Bancorp的季度营收约是REPLIGEN CORP的1.6倍（$314.4M vs $197.9M），Ameris Bancorp净利率更高（35.1% vs 6.7%，领先28.4%），REPLIGEN CORP同比增速更快（13.6% vs 10.0%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 2.3%）
Ameris Bancorp是总部位于美国佐治亚州亚特兰大的银行控股企业，旗下子公司Ameris Bank在佐治亚、阿拉巴马、佛罗里达、北卡罗来纳、南卡罗来纳五州运营全服务网点，另在多州设有抵押贷款专属站点，同时面向个人及企业客户提供便捷的线上及移动银行服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ABCB vs RGEN — 直观对比
营收规模更大
ABCB
是对方的1.6倍
$197.9M
营收增速更快
RGEN
高出3.7%
10.0%
净利率更高
ABCB
高出28.4%
6.7%
两年增速更快
RGEN
近两年复合增速
2.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $314.4M | $197.9M |
| 净利润 | $110.5M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 35.1% | 6.7% |
| 营收同比 | 10.0% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $1.63 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABCBRGEN
| Q1 26 | $314.4M | — | ||
| Q4 25 | $307.1M | $197.9M | ||
| Q3 25 | $314.2M | $188.8M | ||
| Q2 25 | $300.7M | $182.4M | ||
| Q1 25 | $285.9M | $169.2M | ||
| Q4 24 | $290.8M | $174.1M | ||
| Q3 24 | $283.8M | $154.9M | ||
| Q2 24 | $300.6M | $154.1M |
净利润ABCBRGEN
| Q1 26 | $110.5M | — | ||
| Q4 25 | $108.4M | $13.3M | ||
| Q3 25 | $106.0M | $14.9M | ||
| Q2 25 | $109.8M | $14.9M | ||
| Q1 25 | $87.9M | $5.8M | ||
| Q4 24 | $94.4M | $-30.3M | ||
| Q3 24 | $99.2M | $-654.0K | ||
| Q2 24 | $90.8M | $3.3M |
毛利率ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 45.9% | 9.0% | ||
| Q3 25 | 43.6% | 8.9% | ||
| Q2 25 | 47.4% | 7.6% | ||
| Q1 25 | 39.5% | 3.9% | ||
| Q4 24 | 43.3% | -17.7% | ||
| Q3 24 | 44.4% | -5.1% | ||
| Q2 24 | 42.1% | 1.0% |
净利率ABCBRGEN
| Q1 26 | 35.1% | — | ||
| Q4 25 | 44.2% | 6.7% | ||
| Q3 25 | 33.7% | 7.9% | ||
| Q2 25 | 36.5% | 8.2% | ||
| Q1 25 | 30.8% | 3.4% | ||
| Q4 24 | 42.5% | -17.4% | ||
| Q3 24 | 35.0% | -0.4% | ||
| Q2 24 | 30.2% | 2.2% |
每股收益（稀释后）ABCBRGEN
| Q1 26 | $1.63 | — | ||
| Q4 25 | $1.59 | $0.24 | ||
| Q3 25 | $1.54 | $0.26 | ||
| Q2 25 | $1.60 | $0.26 | ||
| Q1 25 | $1.27 | $0.10 | ||
| Q4 24 | $1.35 | $-0.55 | ||
| Q3 24 | $1.44 | $-0.01 | ||
| Q2 24 | $1.32 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $4.1B | $2.1B |
| 总资产 | $28.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ABCBRGEN
| Q1 26 | $4.1B | — | ||
| Q4 25 | $4.1B | $2.1B | ||
| Q3 25 | $4.0B | $2.1B | ||
| Q2 25 | $3.9B | $2.1B | ||
| Q1 25 | $3.8B | $2.0B | ||
| Q4 24 | $3.8B | $2.0B | ||
| Q3 24 | $3.7B | $2.0B | ||
| Q2 24 | $3.6B | $2.0B |
总资产ABCBRGEN
| Q1 26 | $28.1B | — | ||
| Q4 25 | $27.5B | $2.9B | ||
| Q3 25 | $27.1B | $2.9B | ||
| Q2 25 | $26.7B | $2.9B | ||
| Q1 25 | $26.5B | $2.9B | ||
| Q4 24 | $26.3B | $2.8B | ||
| Q3 24 | $26.4B | $2.8B | ||
| Q2 24 | $26.5B | $2.9B |
负债/权益比ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $390.2M | $25.7M | ||
| Q3 25 | $104.9M | $48.1M | ||
| Q2 25 | $61.4M | $28.6M | ||
| Q1 25 | $116.9M | $15.0M | ||
| Q4 24 | $154.2M | $39.2M | ||
| Q3 24 | $102.2M | $49.3M | ||
| Q2 24 | $-97.1M | $42.2M |
自由现金流ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $369.6M | $17.6M | ||
| Q3 25 | $100.5M | $43.4M | ||
| Q2 25 | $53.7M | $21.5M | ||
| Q1 25 | $114.2M | $11.4M | ||
| Q4 24 | $140.7M | $33.6M | ||
| Q3 24 | $99.8M | $42.3M | ||
| Q2 24 | $-100.3M | $37.4M |
自由现金流率ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 120.4% | 8.9% | ||
| Q3 25 | 32.0% | 23.0% | ||
| Q2 25 | 17.9% | 11.8% | ||
| Q1 25 | 39.9% | 6.8% | ||
| Q4 24 | 48.4% | 19.3% | ||
| Q3 24 | 35.2% | 27.3% | ||
| Q2 24 | -33.4% | 24.3% |
资本支出强度ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 6.7% | 4.1% | ||
| Q3 25 | 1.4% | 2.5% | ||
| Q2 25 | 2.5% | 3.9% | ||
| Q1 25 | 0.9% | 2.1% | ||
| Q4 24 | 4.6% | 3.2% | ||
| Q3 24 | 0.8% | 4.5% | ||
| Q2 24 | 1.1% | 3.1% |
现金转化率ABCBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 3.60× | 1.93× | ||
| Q3 25 | 0.99× | 3.23× | ||
| Q2 25 | 0.56× | 1.92× | ||
| Q1 25 | 1.33× | 2.57× | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | -1.07× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
